News Release from HHS.gov: HHS commits up to $300 million over 10 year…
Coronavirus Resources:
Tech Watch
If you are interested in partnering with the federal government on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners.
To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.
EZ BAA
Novel Coronavirus EZ-BAA
To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.
BAA
BARDA is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003).
BARDA scientists started working with private-sector partners in January 2020, days after the novel coronavirus was first reported. BARDA continues to support test development and has expanded support of programs that increase testing speed and capacity for lab tests, as well as broaden access to testing by developing point-of-care and home-use platforms.
Every American can make a difference in our country's response to COVID-19.
Learn more about how you can contribute to the fight.
